Warrants Finder
Your selection:
426 Results
| GW4NAT | Vertex Pharmaceuticals Inc./OS/Call [460]/GOLDS | - | - | 460.000 | call | Vertex Pharmaceuticals Inc. | - | 39.196% | 0.663 | -0.079 | 3.534 | 06/17/2027 | 0.100 | Goldman Sachs | ||
| GW4RBE | Vertex Pharmaceuticals Inc./OS/Call [460]/GOLDS | - | - | 460.000 | call | Vertex Pharmaceuticals Inc. | - | 38.934% | 0.652 | -0.104 | 4.611 | 01/15/2027 | 0.100 | Goldman Sachs | ||
| GW4WHG | Vertex Pharmaceuticals Inc./OS/Call [460]/GOLDS | - | - | 460.000 | call | Vertex Pharmaceuticals Inc. | - | 39.725% | 0.656 | -0.092 | 3.995 | 03/19/2027 | 0.100 | Goldman Sachs | ||
| JH5U1B | Vertex Pharmaceuticals Inc./OS/Call [460]/JPM | - | - | 460.000 | call | Vertex Pharmaceuticals Inc. | - | 42.077% | 0.656 | -0.183 | 6.898 | 09/18/2026 | 0.100 | JP Morgan | ||
| JH5SJH | Vertex Pharmaceuticals Inc./OS/Call [460]/JPM | - | - | 460.000 | call | Vertex Pharmaceuticals Inc. | - | 41.201% | 0.649 | -0.117 | 4.743 | 12/18/2026 | 0.100 | JP Morgan | ||
| JH9BES | Vertex Pharmaceuticals Inc./OS/Call [460]/JPM | - | - | 460.000 | call | Vertex Pharmaceuticals Inc. | - | 42.566% | 0.649 | -0.112 | 4.303 | 01/15/2027 | 0.100 | JP Morgan | ||
| JE11YR | Vertex Pharmaceuticals Inc./OS/Call [460]/JPMD | - | - | 460.000 | call | Vertex Pharmaceuticals Inc. | - | 43.674% | 0.654 | -0.099 | 3.715 | 03/19/2027 | 0.100 | JP Morgan | ||
| JE9DHR | Vertex Pharmaceuticals Inc./OS/Call [460]/JPMD | - | - | 460.000 | call | Vertex Pharmaceuticals Inc. | - | 42.702% | 0.662 | -0.084 | 3.315 | 06/17/2027 | 0.100 | JP Morgan | ||
| SX5K5C | Vertex Pharmaceuticals Inc./OS/Call [460]/SOC | - | - | 460.000 | call | Vertex Pharmaceuticals Inc. | - | 41.229% | 0.652 | -0.108 | 4.390 | 01/15/2027 | 0.100 | Société Générale | ||
| FD1YTN | Vertex Pharmaceuticals Inc./OS/Call [460]/SOC | - | - | 460.000 | call | Vertex Pharmaceuticals Inc. | - | 40.962% | 0.661 | -0.178 | 7.025 | 09/18/2026 | 0.100 | Société Générale | ||
| FE1AXP | Vertex Pharmaceuticals Inc./OS/Call [460]/SOC | - | - | 460.000 | call | Vertex Pharmaceuticals Inc. | - | 39.652% | 0.651 | -0.114 | 4.883 | 12/18/2026 | 0.100 | Société Générale | ||
| FE1AXU | Vertex Pharmaceuticals Inc./OS/Call [460]/SOC | - | - | 460.000 | call | Vertex Pharmaceuticals Inc. | - | 42.376% | 0.653 | -0.096 | 3.804 | 03/19/2027 | 0.100 | Société Générale | ||
| FE58UZ | Vertex Pharmaceuticals Inc./OS/Call [460]/SOC | - | - | 460.000 | call | Vertex Pharmaceuticals Inc. | - | 41.325% | 0.663 | -0.082 | 3.396 | 06/17/2027 | 0.100 | Société Générale | ||
| FE58VG | Vertex Pharmaceuticals Inc./OS/Call [460]/SOC | - | - | 460.000 | call | Vertex Pharmaceuticals Inc. | - | 40.974% | 0.679 | -0.063 | 2.789 | 01/21/2028 | 0.100 | Société Générale | ||
| JH5U1N | Vertex Pharmaceuticals Inc./OS/Call [470]/JPM | - | - | 470.000 | call | Vertex Pharmaceuticals Inc. | - | 41.815% | 0.610 | -0.188 | 7.322 | 09/18/2026 | 0.100 | JP Morgan | ||
| JH5SJS | Vertex Pharmaceuticals Inc./OS/Call [470]/JPM | - | - | 470.000 | call | Vertex Pharmaceuticals Inc. | - | 41.131% | 0.618 | -0.119 | 4.915 | 12/18/2026 | 0.100 | JP Morgan | ||
| JH9BET | Vertex Pharmaceuticals Inc./OS/Call [470]/JPM | - | - | 470.000 | call | Vertex Pharmaceuticals Inc. | - | 42.106% | 0.622 | -0.112 | 4.470 | 01/15/2027 | 0.100 | JP Morgan | ||
| MM215V |  | Vertex Pharmaceuticals Inc./OS/Call [475]/MS | - | - | 475.000 | call | Vertex Pharmaceuticals Inc. | - | 40.236% | 0.602 | -0.012 | 5.090 | 12/18/2026 | 0.010 | Morgan Stanley | |
| MM215U | | Vertex Pharmaceuticals Inc./OS/Call [475]/MS | - | - | 475.000 | call | Vertex Pharmaceuticals Inc. | - | 42.445% | 0.633 | -0.009 | 3.432 | 06/17/2027 | 0.010 | Morgan Stanley | |
| GW3T4J | Vertex Pharmaceuticals Inc./OS/Call [480]/GOLDS | - | - | 480.000 | call | Vertex Pharmaceuticals Inc. | - | 38.367% | 0.593 | -0.106 | 4.981 | 01/15/2027 | 0.100 | Goldman Sachs | ||
| GW3T6M | Vertex Pharmaceuticals Inc./OS/Call [480]/GOLDS | - | - | 480.000 | call | Vertex Pharmaceuticals Inc. | - | 39.023% | 0.606 | -0.093 | 4.276 | 03/19/2027 | 0.100 | Goldman Sachs | ||
| GW5276 | Vertex Pharmaceuticals Inc./OS/Call [480]/GOLDS | - | - | 480.000 | call | Vertex Pharmaceuticals Inc. | - | 38.015% | 0.622 | -0.079 | 3.778 | 06/17/2027 | 0.100 | Goldman Sachs | ||
| JH3B3B | Vertex Pharmaceuticals Inc./OS/Call [480]/JPM | - | - | 480.000 | call | Vertex Pharmaceuticals Inc. | - | 41.604% | 0.594 | -0.113 | 4.650 | 01/15/2027 | 0.100 | JP Morgan | ||
| JH5U1L | Vertex Pharmaceuticals Inc./OS/Call [480]/JPM | - | - | 480.000 | call | Vertex Pharmaceuticals Inc. | - | 43.339% | 0.561 | -0.197 | 7.483 | 09/18/2026 | 0.100 | JP Morgan | ||
| JH5SJJ | Vertex Pharmaceuticals Inc./OS/Call [480]/JPM | - | - | 480.000 | call | Vertex Pharmaceuticals Inc. | - | 40.775% | 0.587 | -0.120 | 5.116 | 12/18/2026 | 0.100 | JP Morgan | ||
| JE05DK | Vertex Pharmaceuticals Inc./OS/Call [480]/JPMD | - | - | 480.000 | call | Vertex Pharmaceuticals Inc. | - | 40.836% | 0.570 | -0.155 | 6.580 | 10/16/2026 | 0.100 | JP Morgan | ||
| JE11YT | Vertex Pharmaceuticals Inc./OS/Call [480]/JPMD | - | - | 480.000 | call | Vertex Pharmaceuticals Inc. | - | 43.115% | 0.607 | -0.100 | 3.941 | 03/19/2027 | 0.100 | JP Morgan | ||
| JE81LQ | Vertex Pharmaceuticals Inc./OS/Call [480]/JPMD | - | - | 480.000 | call | Vertex Pharmaceuticals Inc. | - | 42.161% | 0.623 | -0.085 | 3.487 | 06/17/2027 | 0.100 | JP Morgan | ||
| JY32WF | Vertex Pharmaceuticals Inc./OS/Call [480]/JPMD | - | - | 480.000 | call | Vertex Pharmaceuticals Inc. | - | 44.457% | 0.551 | -0.280 | 9.905 | 08/21/2026 | 0.100 | JP Morgan | ||
| SX5K5D | Vertex Pharmaceuticals Inc./OS/Call [480]/SOC | - | - | 480.000 | call | Vertex Pharmaceuticals Inc. | - | 40.508% | 0.596 | -0.110 | 4.734 | 01/15/2027 | 0.100 | Société Générale | ||
| FE1AXK | Vertex Pharmaceuticals Inc./OS/Call [480]/SOC | - | - | 480.000 | call | Vertex Pharmaceuticals Inc. | - | 40.798% | 0.561 | -0.187 | 7.903 | 09/18/2026 | 0.100 | Société Générale | ||
| FE4XZ2 | Vertex Pharmaceuticals Inc./OS/Call [480]/SOC | - | - | 480.000 | call | Vertex Pharmaceuticals Inc. | - | 39.508% | 0.586 | -0.117 | 5.259 | 12/18/2026 | 0.100 | Société Générale | ||
| FE58HH | Vertex Pharmaceuticals Inc./OS/Call [480]/SOC | - | - | 480.000 | call | Vertex Pharmaceuticals Inc. | - | 41.695% | 0.607 | -0.098 | 4.050 | 03/19/2027 | 0.100 | Société Générale | ||
| FE58U0 | Vertex Pharmaceuticals Inc./OS/Call [480]/SOC | - | - | 480.000 | call | Vertex Pharmaceuticals Inc. | - | 40.661% | 0.623 | -0.083 | 3.587 | 06/17/2027 | 0.100 | Société Générale | ||
| FE58VH | Vertex Pharmaceuticals Inc./OS/Call [480]/SOC | - | - | 480.000 | call | Vertex Pharmaceuticals Inc. | - | 40.373% | 0.647 | -0.064 | 2.912 | 01/21/2028 | 0.100 | Société Générale | ||
| VH625G | | Vertex Pharmaceuticals Inc./OS/Call [480]/VONT | - | - | 480.000 | call | Vertex Pharmaceuticals Inc. | - | 39.565% | 0.593 | -0.108 | 4.851 | 01/15/2027 | 0.100 | Vontobel | |
| JH3B3A | Vertex Pharmaceuticals Inc./OS/Call [490]/JPM | - | - | 490.000 | call | Vertex Pharmaceuticals Inc. | - | 41.263% | 0.566 | -0.112 | 4.818 | 01/15/2027 | 0.100 | JP Morgan | ||
| JH5VLU | Vertex Pharmaceuticals Inc./OS/Call [490]/JPM | - | - | 490.000 | call | Vertex Pharmaceuticals Inc. | - | 40.791% | 0.511 | -0.187 | 8.340 | 09/18/2026 | 0.100 | JP Morgan | ||
| JH5SJG | Vertex Pharmaceuticals Inc./OS/Call [490]/JPM | - | - | 490.000 | call | Vertex Pharmaceuticals Inc. | - | 40.800% | 0.556 | -0.120 | 5.286 | 12/18/2026 | 0.100 | JP Morgan | ||
| GJ8ZUS | Vertex Pharmaceuticals Inc./OS/Call [500]/GOLDS | - | - | 500.000 | call | Vertex Pharmaceuticals Inc. | - | 36.555% | 0.518 | -0.110 | 6.036 | 12/18/2026 | 0.100 | Goldman Sachs | ||
| GV0K08 | Vertex Pharmaceuticals Inc./OS/Call [500]/GOLDS | - | - | 500.000 | call | Vertex Pharmaceuticals Inc. | - | 37.668% | 0.532 | -0.105 | 5.387 | 01/15/2027 | 0.100 | Goldman Sachs | ||
| GV70J6 | Vertex Pharmaceuticals Inc./OS/Call [500]/GOLDS | - | - | 500.000 | call | Vertex Pharmaceuticals Inc. | - | 37.650% | 0.459 | -0.170 | 9.410 | 09/18/2026 | 0.100 | Goldman Sachs | ||
| GV87PB | Vertex Pharmaceuticals Inc./OS/Call [500]/GOLDS | - | - | 500.000 | call | Vertex Pharmaceuticals Inc. | - | 37.902% | 0.577 | -0.080 | 3.969 | 06/17/2027 | 0.100 | Goldman Sachs | ||
| GW01DL | Vertex Pharmaceuticals Inc./OS/Call [500]/GOLDS | - | - | 500.000 | call | Vertex Pharmaceuticals Inc. | - | 40.579% | 0.617 | -0.065 | 2.990 | 01/21/2028 | 0.100 | Goldman Sachs | ||
| GW1W1X | Vertex Pharmaceuticals Inc./OS/Call [500]/GOLDS | - | - | 500.000 | call | Vertex Pharmaceuticals Inc. | - | 38.894% | 0.556 | -0.093 | 4.506 | 03/19/2027 | 0.100 | Goldman Sachs | ||
| GW85MB | Vertex Pharmaceuticals Inc./OS/Call [500]/GOLDS | - | - | 500.000 | call | Vertex Pharmaceuticals Inc. | - | 35.672% | 0.478 | -0.137 | 8.182 | 10/16/2026 | 0.100 | Goldman Sachs | ||
| GW8MX4 | Vertex Pharmaceuticals Inc./OS/Call [500]/GOLDS | - | - | 500.000 | call | Vertex Pharmaceuticals Inc. | - | 39.913% | 0.412 | -0.243 | 12.716 | 08/21/2026 | 0.100 | Goldman Sachs | ||
| JZ6TNH | Vertex Pharmaceuticals Inc./OS/Call [500]/JPMD | - | - | 500.000 | call | Vertex Pharmaceuticals Inc. | - | 41.163% | 0.538 | -0.112 | 4.972 | 01/15/2027 | 0.100 | JP Morgan | ||
| JE04W2 | Vertex Pharmaceuticals Inc./OS/Call [500]/JPMD | - | - | 500.000 | call | Vertex Pharmaceuticals Inc. | - | 40.770% | 0.462 | -0.184 | 8.790 | 09/18/2026 | 0.100 | JP Morgan | ||
| JE0B5K | Vertex Pharmaceuticals Inc./OS/Call [500]/JPMD | - | - | 500.000 | call | Vertex Pharmaceuticals Inc. | - | 40.138% | 0.488 | -0.152 | 7.286 | 10/16/2026 | 0.100 | JP Morgan |